drugset / Trial / NCT02363803

Lidocaine for Diabetic Peripheral Neuropathy

NCT02363803 ↗

RandomizedCrossoverDouble-blindTreatment

Summary

Diabetic nerve pain \[painful diabetic peripheral neuropathy\] is a common medical problem with few reliably effective treatments. There is some evidence that sensory testing may help determine how individuals will respond to analgesic therapy. In this study, the investigators are evaluating the relationship between sensory testing and subject response to lidocaine infusion therapy.

Timeline

Start
2015-02
Primary completion
2018-10-17
Completion
2018-10-17

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 5 mg/kg Intravenous